| 000 | 01477 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514211904.0 | ||
| 264 | 0 | _c20050419 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a0269-9370 | ||
| 024 | 7 |
_a10.1097/00002030-200410210-00017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGonzález de Requena, Daniel | |
| 245 | 0 | 0 |
_aHigher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cOct 2004 |
||
| 300 |
_a2091-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlkynes |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzoxazines |
| 650 | 0 | 4 | _aCyclopropanes |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 |
_aHIV Infections _xblood |
| 650 | 0 | 4 |
_aHIV-1 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aNevirapine _xtherapeutic use |
| 650 | 0 | 4 |
_aOxazines _xblood |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xblood |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aGallego, Oscar | |
| 700 | 1 | _aCorral, Angélica | |
| 700 | 1 | _aJiménez-Nácher, Inmaculada | |
| 700 | 1 | _aSoriano, Vincent | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 18 _gno. 15 _gp. 2091-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002030-200410210-00017 _zAvailable from publisher's website |
| 999 |
_c15262717 _d15262717 |
||